 | • レポートコード：QYR2104Z5359 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、128ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療機器 |
| Single User | ￥553,800 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥830,700 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,107,600 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、軟組織同種移植のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ヒアリン、エラスティック、フィブロ）、用途別市場規模（病院、外来手術センター、歯科医院）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・軟組織同種移植の市場動向 ・企業の競争状況、市場シェア ・軟組織同種移植の種類別市場規模（ヒアリン、エラスティック、フィブロ） ・軟組織同種移植の用途別市場規模（病院、外来手術センター、歯科医院） ・軟組織同種移植の北米市場規模2016-2027（アメリカ、カナダ） ・軟組織同種移植のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・軟組織同種移植のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・軟組織同種移植の中南米市場規模2016-2027（メキシコ、ブラジル） ・軟組織同種移植の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Allergan、B. Braun Melsungen、CONMED、Xtant Medical Holdings、Alliqua BioMedical、ALON SOURCE GROUP、AlloSource、C. R. Bard、Arthrex、Bone Bank Allografts、Osiris Therapeutics、MiMedx Group、Integra LifeSciences、Organogenesis、RTI Surgical、Lattice Biologics、Globus Medical、Zimmer Biomet Holdings、Straumann Holding） ・結論 |
Soft tissue refers to human skin, subcutaneous tissue, muscle, tendon, ligament, joint capsule, synovial capsule, nerve, blood vessel, etc.
Increasing prevalence of degenerative joint diseases and high definition designed technology are the major drivers of the global soft tissue allografts market.
Market Analysis and Insights: Global Soft Tissue Allografts Market
The global Soft Tissue Allografts market size is projected to reach US$ 4008.5 million by 2026, from US$ 2800 million in 2019, at a CAGR of 5.2% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Soft Tissue Allografts market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Soft Tissue Allografts market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Soft Tissue Allografts market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Soft Tissue Allografts market.
Global Soft Tissue Allografts Scope and Market Size
Soft Tissue Allografts market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Soft Tissue Allografts market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Hyaline
Elastic
Fibro
Segment by Application
Hospitals
Ambulatory Surgical Centers
Dental Clinics
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Allergan
B. Braun Melsungen
CONMED
Xtant Medical Holdings
Alliqua BioMedical
ALON SOURCE GROUP
AlloSource
C. R. Bard
Arthrex
Xtant Medical Holdings
Alliqua BioMedical
MiMedx Group
Integra LifeSciences
Organogenesis
RTI Surgical
Lattice Biologics
Globus Medical
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Soft Tissue Allografts Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Hyaline
1.2.3 Elastic
1.2.4 Fibro
1.3 Market by Application
1.3.1 Global Soft Tissue Allografts Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Dental Clinics
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Soft Tissue Allografts Market Perspective (2016-2027)
2.2 Soft Tissue Allografts Growth Trends by Regions
2.2.1 Soft Tissue Allografts Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Soft Tissue Allografts Historic Market Share by Regions (2016-2021)
2.2.3 Soft Tissue Allografts Forecasted Market Size by Regions (2022-2027)
2.3 Soft Tissue Allografts Industry Dynamic
2.3.1 Soft Tissue Allografts Market Trends
2.3.2 Soft Tissue Allografts Market Drivers
2.3.3 Soft Tissue Allografts Market Challenges
2.3.4 Soft Tissue Allografts Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Soft Tissue Allografts Players by Revenue
3.1.1 Global Top Soft Tissue Allografts Players by Revenue (2016-2021)
3.1.2 Global Soft Tissue Allografts Revenue Market Share by Players (2016-2021)
3.2 Global Soft Tissue Allografts Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Soft Tissue Allografts Revenue
3.4 Global Soft Tissue Allografts Market Concentration Ratio
3.4.1 Global Soft Tissue Allografts Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Soft Tissue Allografts Revenue in 2020
3.5 Soft Tissue Allografts Key Players Head office and Area Served
3.6 Key Players Soft Tissue Allografts Product Solution and Service
3.7 Date of Enter into Soft Tissue Allografts Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Soft Tissue Allografts Breakdown Data by Type
4.1 Global Soft Tissue Allografts Historic Market Size by Type (2016-2021)
4.2 Global Soft Tissue Allografts Forecasted Market Size by Type (2022-2027)
5 Soft Tissue Allografts Breakdown Data by Application
5.1 Global Soft Tissue Allografts Historic Market Size by Application (2016-2021)
5.2 Global Soft Tissue Allografts Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Soft Tissue Allografts Market Size (2016-2027)
6.2 North America Soft Tissue Allografts Market Size by Type
6.2.1 North America Soft Tissue Allografts Market Size by Type (2016-2021)
6.2.2 North America Soft Tissue Allografts Market Size by Type (2022-2027)
6.2.3 North America Soft Tissue Allografts Market Size by Type (2016-2027)
6.3 North America Soft Tissue Allografts Market Size by Application
6.3.1 North America Soft Tissue Allografts Market Size by Application (2016-2021)
6.3.2 North America Soft Tissue Allografts Market Size by Application (2022-2027)
6.3.3 North America Soft Tissue Allografts Market Size by Application (2016-2027)
6.4 North America Soft Tissue Allografts Market Size by Country
6.4.1 North America Soft Tissue Allografts Market Size by Country (2016-2021)
6.4.2 North America Soft Tissue Allografts Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Soft Tissue Allografts Market Size (2016-2027)
7.2 Europe Soft Tissue Allografts Market Size by Type
7.2.1 Europe Soft Tissue Allografts Market Size by Type (2016-2021)
7.2.2 Europe Soft Tissue Allografts Market Size by Type (2022-2027)
7.2.3 Europe Soft Tissue Allografts Market Size by Type (2016-2027)
7.3 Europe Soft Tissue Allografts Market Size by Application
7.3.1 Europe Soft Tissue Allografts Market Size by Application (2016-2021)
7.3.2 Europe Soft Tissue Allografts Market Size by Application (2022-2027)
7.3.3 Europe Soft Tissue Allografts Market Size by Application (2016-2027)
7.4 Europe Soft Tissue Allografts Market Size by Country
7.4.1 Europe Soft Tissue Allografts Market Size by Country (2016-2021)
7.4.2 Europe Soft Tissue Allografts Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Soft Tissue Allografts Market Size (2016-2027)
8.2 Asia-Pacific Soft Tissue Allografts Market Size by Type
8.2.1 Asia-Pacific Soft Tissue Allografts Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Soft Tissue Allografts Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Soft Tissue Allografts Market Size by Type (2016-2027)
8.3 Asia-Pacific Soft Tissue Allografts Market Size by Application
8.3.1 Asia-Pacific Soft Tissue Allografts Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Soft Tissue Allografts Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Soft Tissue Allografts Market Size by Application (2016-2027)
8.4 Asia-Pacific Soft Tissue Allografts Market Size by Region
8.4.1 Asia-Pacific Soft Tissue Allografts Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Soft Tissue Allografts Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Soft Tissue Allografts Market Size (2016-2027)
9.2 Latin America Soft Tissue Allografts Market Size by Type
9.2.1 Latin America Soft Tissue Allografts Market Size by Type (2016-2021)
9.2.2 Latin America Soft Tissue Allografts Market Size by Type (2022-2027)
9.2.3 Latin America Soft Tissue Allografts Market Size by Type (2016-2027)
9.3 Latin America Soft Tissue Allografts Market Size by Application
9.3.1 Latin America Soft Tissue Allografts Market Size by Application (2016-2021)
9.3.2 Latin America Soft Tissue Allografts Market Size by Application (2022-2027)
9.3.3 Latin America Soft Tissue Allografts Market Size by Application (2016-2027)
9.4 Latin America Soft Tissue Allografts Market Size by Country
9.4.1 Latin America Soft Tissue Allografts Market Size by Country (2016-2021)
9.4.2 Latin America Soft Tissue Allografts Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Soft Tissue Allografts Market Size (2016-2027)
10.2 Middle East & Africa Soft Tissue Allografts Market Size by Type
10.2.1 Middle East & Africa Soft Tissue Allografts Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Soft Tissue Allografts Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Soft Tissue Allografts Market Size by Type (2016-2027)
10.3 Middle East & Africa Soft Tissue Allografts Market Size by Application
10.3.1 Middle East & Africa Soft Tissue Allografts Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Soft Tissue Allografts Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Soft Tissue Allografts Market Size by Application (2016-2027)
10.4 Middle East & Africa Soft Tissue Allografts Market Size by Country
10.4.1 Middle East & Africa Soft Tissue Allografts Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Soft Tissue Allografts Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Allergan
11.1.1 Allergan Company Details
11.1.2 Allergan Business Overview
11.1.3 Allergan Soft Tissue Allografts Introduction
11.1.4 Allergan Revenue in Soft Tissue Allografts Business (2016-2021)
11.1.5 Allergan Recent Development
11.2 B. Braun Melsungen
11.2.1 B. Braun Melsungen Company Details
11.2.2 B. Braun Melsungen Business Overview
11.2.3 B. Braun Melsungen Soft Tissue Allografts Introduction
11.2.4 B. Braun Melsungen Revenue in Soft Tissue Allografts Business (2016-2021)
11.2.5 B. Braun Melsungen Recent Development
11.3 CONMED
11.3.1 CONMED Company Details
11.3.2 CONMED Business Overview
11.3.3 CONMED Soft Tissue Allografts Introduction
11.3.4 CONMED Revenue in Soft Tissue Allografts Business (2016-2021)
11.3.5 CONMED Recent Development
11.4 Xtant Medical Holdings
11.4.1 Xtant Medical Holdings Company Details
11.4.2 Xtant Medical Holdings Business Overview
11.4.3 Xtant Medical Holdings Soft Tissue Allografts Introduction
11.4.4 Xtant Medical Holdings Revenue in Soft Tissue Allografts Business (2016-2021)
11.4.5 Xtant Medical Holdings Recent Development
11.5 Alliqua BioMedical
11.5.1 Alliqua BioMedical Company Details
11.5.2 Alliqua BioMedical Business Overview
11.5.3 Alliqua BioMedical Soft Tissue Allografts Introduction
11.5.4 Alliqua BioMedical Revenue in Soft Tissue Allografts Business (2016-2021)
11.5.5 Alliqua BioMedical Recent Development
11.6 ALON SOURCE GROUP
11.6.1 ALON SOURCE GROUP Company Details
11.6.2 ALON SOURCE GROUP Business Overview
11.6.3 ALON SOURCE GROUP Soft Tissue Allografts Introduction
11.6.4 ALON SOURCE GROUP Revenue in Soft Tissue Allografts Business (2016-2021)
11.6.5 ALON SOURCE GROUP Recent Development
11.7 AlloSource
11.7.1 AlloSource Company Details
11.7.2 AlloSource Business Overview
11.7.3 AlloSource Soft Tissue Allografts Introduction
11.7.4 AlloSource Revenue in Soft Tissue Allografts Business (2016-2021)
11.7.5 AlloSource Recent Development
11.8 C. R. Bard
11.8.1 C. R. Bard Company Details
11.8.2 C. R. Bard Business Overview
11.8.3 C. R. Bard Soft Tissue Allografts Introduction
11.8.4 C. R. Bard Revenue in Soft Tissue Allografts Business (2016-2021)
11.8.5 C. R. Bard Recent Development
11.9 Arthrex
11.9.1 Arthrex Company Details
11.9.2 Arthrex Business Overview
11.9.3 Arthrex Soft Tissue Allografts Introduction
11.9.4 Arthrex Revenue in Soft Tissue Allografts Business (2016-2021)
11.9.5 Arthrex Recent Development
11.10 Bone Bank Allografts
11.10.1 Bone Bank Allografts Company Details
11.10.2 Bone Bank Allografts Business Overview
11.10.3 Bone Bank Allografts Soft Tissue Allografts Introduction
11.10.4 Bone Bank Allografts Revenue in Soft Tissue Allografts Business (2016-2021)
11.10.5 Bone Bank Allografts Recent Development
11.11 Osiris Therapeutics
11.11.1 Osiris Therapeutics Company Details
11.11.2 Osiris Therapeutics Business Overview
11.11.3 Osiris Therapeutics Soft Tissue Allografts Introduction
11.11.4 Osiris Therapeutics Revenue in Soft Tissue Allografts Business (2016-2021)
11.11.5 Osiris Therapeutics Recent Development
11.12 MiMedx Group
11.12.1 MiMedx Group Company Details
11.12.2 MiMedx Group Business Overview
11.12.3 MiMedx Group Soft Tissue Allografts Introduction
11.12.4 MiMedx Group Revenue in Soft Tissue Allografts Business (2016-2021)
11.12.5 MiMedx Group Recent Development
11.13 Integra LifeSciences
11.13.1 Integra LifeSciences Company Details
11.13.2 Integra LifeSciences Business Overview
11.13.3 Integra LifeSciences Soft Tissue Allografts Introduction
11.13.4 Integra LifeSciences Revenue in Soft Tissue Allografts Business (2016-2021)
11.13.5 Integra LifeSciences Recent Development
11.14 Organogenesis
11.14.1 Organogenesis Company Details
11.14.2 Organogenesis Business Overview
11.14.3 Organogenesis Soft Tissue Allografts Introduction
11.14.4 Organogenesis Revenue in Soft Tissue Allografts Business (2016-2021)
11.14.5 Organogenesis Recent Development
11.15 RTI Surgical
11.15.1 RTI Surgical Company Details
11.15.2 RTI Surgical Business Overview
11.15.3 RTI Surgical Soft Tissue Allografts Introduction
11.15.4 RTI Surgical Revenue in Soft Tissue Allografts Business (2016-2021)
11.15.5 RTI Surgical Recent Development
11.16 Lattice Biologics
11.16.1 Lattice Biologics Company Details
11.16.2 Lattice Biologics Business Overview
11.16.3 Lattice Biologics Soft Tissue Allografts Introduction
11.16.4 Lattice Biologics Revenue in Soft Tissue Allografts Business (2016-2021)
11.16.5 Lattice Biologics Recent Development
11.17 Globus Medical
11.17.1 Globus Medical Company Details
11.17.2 Globus Medical Business Overview
11.17.3 Globus Medical Soft Tissue Allografts Introduction
11.17.4 Globus Medical Revenue in Soft Tissue Allografts Business (2016-2021)
11.17.5 Globus Medical Recent Development
11.18 Zimmer Biomet Holdings
11.18.1 Zimmer Biomet Holdings Company Details
11.18.2 Zimmer Biomet Holdings Business Overview
11.18.3 Zimmer Biomet Holdings Soft Tissue Allografts Introduction
11.18.4 Zimmer Biomet Holdings Revenue in Soft Tissue Allografts Business (2016-2021)
11.18.5 Zimmer Biomet Holdings Recent Development
11.18 Straumann Holding
.1 Straumann Holding Company Details
.2 Straumann Holding Business Overview
.3 Straumann Holding Soft Tissue Allografts Introduction
.4 Straumann Holding Revenue in Soft Tissue Allografts Business (2016-2021)
.5 Straumann Holding Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Soft Tissue Allografts Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Hyaline
Table 3. Key Players of Elastic
Table 4. Key Players of Fibro
Table 5. Global Soft Tissue Allografts Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Soft Tissue Allografts Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Soft Tissue Allografts Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Soft Tissue Allografts Market Share by Regions (2016-2021)
Table 9. Global Soft Tissue Allografts Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Soft Tissue Allografts Market Share by Regions (2022-2027)
Table 11. Soft Tissue Allografts Market Trends
Table 12. Soft Tissue Allografts Market Drivers
Table 13. Soft Tissue Allografts Market Challenges
Table 14. Soft Tissue Allografts Market Restraints
Table 15. Global Soft Tissue Allografts Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Soft Tissue Allografts Market Share by Players (2016-2021)
Table 17. Global Top Soft Tissue Allografts Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Soft Tissue Allografts as of 2020)
Table 18. Ranking of Global Top Soft Tissue Allografts Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Soft Tissue Allografts Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Soft Tissue Allografts Product Solution and Service
Table 22. Date of Enter into Soft Tissue Allografts Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Soft Tissue Allografts Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Soft Tissue Allografts Revenue Market Share by Type (2016-2021)
Table 26. Global Soft Tissue Allografts Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Soft Tissue Allografts Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Soft Tissue Allografts Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Soft Tissue Allografts Revenue Market Share by Application (2016-2021)
Table 30. Global Soft Tissue Allografts Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Soft Tissue Allografts Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Soft Tissue Allografts Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Soft Tissue Allografts Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Soft Tissue Allografts Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Soft Tissue Allografts Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Soft Tissue Allografts Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Soft Tissue Allografts Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Soft Tissue Allografts Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Soft Tissue Allografts Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Soft Tissue Allografts Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Soft Tissue Allografts Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Soft Tissue Allografts Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Soft Tissue Allografts Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Soft Tissue Allografts Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Soft Tissue Allografts Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Soft Tissue Allografts Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Soft Tissue Allografts Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Soft Tissue Allografts Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Soft Tissue Allografts Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Soft Tissue Allografts Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Soft Tissue Allografts Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Soft Tissue Allografts Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Soft Tissue Allografts Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Soft Tissue Allografts Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Soft Tissue Allografts Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Soft Tissue Allografts Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Soft Tissue Allografts Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Soft Tissue Allografts Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Soft Tissue Allografts Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Soft Tissue Allografts Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Soft Tissue Allografts Market Size by Country (2022-2027) & (US$ Million)
Table 62. Allergan Company Details
Table 63. Allergan Business Overview
Table 64. Allergan Soft Tissue Allografts Product
Table 65. Allergan Revenue in Soft Tissue Allografts Business (2016-2021) & (US$ Million)
Table 66. Allergan Recent Development
Table 67. B. Braun Melsungen Company Details
Table 68. B. Braun Melsungen Business Overview
Table 69. B. Braun Melsungen Soft Tissue Allografts Product
Table 70. B. Braun Melsungen Revenue in Soft Tissue Allografts Business (2016-2021) & (US$ Million)
Table 71. B. Braun Melsungen Recent Development
Table 72. CONMED Company Details
Table 73. CONMED Business Overview
Table 74. CONMED Soft Tissue Allografts Product
Table 75. CONMED Revenue in Soft Tissue Allografts Business (2016-2021) & (US$ Million)
Table 76. CONMED Recent Development
Table 77. Xtant Medical Holdings Company Details
Table 78. Xtant Medical Holdings Business Overview
Table 79. Xtant Medical Holdings Soft Tissue Allografts Product
Table 80. Xtant Medical Holdings Revenue in Soft Tissue Allografts Business (2016-2021) & (US$ Million)
Table 81. Xtant Medical Holdings Recent Development
Table 82. Alliqua BioMedical Company Details
Table 83. Alliqua BioMedical Business Overview
Table 84. Alliqua BioMedical Soft Tissue Allografts Product
Table 85. Alliqua BioMedical Revenue in Soft Tissue Allografts Business (2016-2021) & (US$ Million)
Table 86. Alliqua BioMedical Recent Development
Table 87. ALON SOURCE GROUP Company Details
Table 88. ALON SOURCE GROUP Business Overview
Table 89. ALON SOURCE GROUP Soft Tissue Allografts Product
Table 90. ALON SOURCE GROUP Revenue in Soft Tissue Allografts Business (2016-2021) & (US$ Million)
Table 91. ALON SOURCE GROUP Recent Development
Table 92. AlloSource Company Details
Table 93. AlloSource Business Overview
Table 94. AlloSource Soft Tissue Allografts Product
Table 95. AlloSource Revenue in Soft Tissue Allografts Business (2016-2021) & (US$ Million)
Table 96. AlloSource Recent Development
Table 97. C. R. Bard Company Details
Table 98. C. R. Bard Business Overview
Table 99. C. R. Bard Revenue in Soft Tissue Allografts Business (2016-2021) & (US$ Million)
Table 100. C. R. Bard Recent Development
Table 101. Arthrex Company Details
Table 102. Arthrex Business Overview
Table 103. Arthrex Soft Tissue Allografts Product
Table 104. Arthrex Revenue in Soft Tissue Allografts Business (2016-2021) & (US$ Million)
Table 105. Arthrex Recent Development
Table 106. Bone Bank Allografts Company Details
Table 107. Bone Bank Allografts Business Overview
Table 108. Bone Bank Allografts Soft Tissue Allografts Product
Table 109. Bone Bank Allografts Revenue in Soft Tissue Allografts Business (2016-2021) & (US$ Million)
Table 110. Bone Bank Allografts Recent Development
Table 111. Osiris Therapeutics Company Details
Table 112. Osiris Therapeutics Business Overview
Table 113. Osiris Therapeutics Soft Tissue Allografts Product
Table 114. Osiris Therapeutics Revenue in Soft Tissue Allografts Business (2016-2021) & (US$ Million)
Table 115. Osiris Therapeutics Recent Development
Table 116. MiMedx Group Company Details
Table 117. MiMedx Group Business Overview
Table 118. MiMedx Group Soft Tissue Allografts Product
Table 119. MiMedx Group Revenue in Soft Tissue Allografts Business (2016-2021) & (US$ Million)
Table 120. MiMedx Group Recent Development
Table 121. Integra LifeSciences Company Details
Table 122. Integra LifeSciences Business Overview
Table 123. Integra LifeSciences Soft Tissue Allografts Product
Table 124. Integra LifeSciences Revenue in Soft Tissue Allografts Business (2016-2021) & (US$ Million)
Table 125. Integra LifeSciences Recent Development
Table 126. Organogenesis Company Details
Table 127. Organogenesis Business Overview
Table 128. Organogenesis Soft Tissue Allografts Product
Table 129. Organogenesis Revenue in Soft Tissue Allografts Business (2016-2021) & (US$ Million)
Table 130. Organogenesis Recent Development
Table 131. RTI Surgical Company Details
Table 132. RTI Surgical Business Overview
Table 133. RTI Surgical Soft Tissue Allografts Product
Table 134. RTI Surgical Revenue in Soft Tissue Allografts Business (2016-2021) & (US$ Million)
Table 135. RTI Surgical Recent Development
Table 136. Lattice Biologics Company Details
Table 137. Lattice Biologics Business Overview
Table 138. Lattice Biologics Soft Tissue Allografts Product
Table 139. Lattice Biologics Revenue in Soft Tissue Allografts Business (2016-2021) & (US$ Million)
Table 140. Lattice Biologics Recent Development
Table 141. Globus Medical Company Details
Table 142. Globus Medical Business Overview
Table 143. Globus Medical Soft Tissue Allografts Product
Table 144. Globus Medical Revenue in Soft Tissue Allografts Business (2016-2021) & (US$ Million)
Table 145. Globus Medical Recent Development
Table 146. Zimmer Biomet Holdings Company Details
Table 147. Zimmer Biomet Holdings Business Overview
Table 148. Zimmer Biomet Holdings Soft Tissue Allografts Product
Table 149. Zimmer Biomet Holdings Revenue in Soft Tissue Allografts Business (2016-2021) & (US$ Million)
Table 150. Zimmer Biomet Holdings Recent Development
Table 151. Straumann Holding Company Details
Table 152. Straumann Holding Business Overview
Table 153. Straumann Holding Soft Tissue Allografts Product
Table 154. Straumann Holding Revenue in Soft Tissue Allografts Business (2016-2021) & (US$ Million)
Table 155. Straumann Holding Recent Development
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Soft Tissue Allografts Market Share by Type: 2020 VS 2027
Figure 2. Hyaline Features
Figure 3. Elastic Features
Figure 4. Fibro Features
Figure 5. Global Soft Tissue Allografts Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Ambulatory Surgical Centers Case Studies
Figure 8. Dental Clinics Case Studies
Figure 9. Soft Tissue Allografts Report Years Considered
Figure 10. Global Soft Tissue Allografts Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Soft Tissue Allografts Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Soft Tissue Allografts Market Share by Regions: 2020 VS 2027
Figure 13. Global Soft Tissue Allografts Market Share by Regions (2022-2027)
Figure 14. Global Soft Tissue Allografts Market Share by Players in 2020
Figure 15. Global Top Soft Tissue Allografts Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Soft Tissue Allografts as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Soft Tissue Allografts Revenue in 2020
Figure 17. Global Soft Tissue Allografts Revenue Market Share by Type (2016-2021)
Figure 18. Global Soft Tissue Allografts Revenue Market Share by Type (2022-2027)
Figure 19. North America Soft Tissue Allografts Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Soft Tissue Allografts Market Share by Type (2016-2027)
Figure 21. North America Soft Tissue Allografts Market Share by Application (2016-2027)
Figure 22. North America Soft Tissue Allografts Market Share by Country (2016-2027)
Figure 23. United States Soft Tissue Allografts Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Soft Tissue Allografts Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Soft Tissue Allografts Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Soft Tissue Allografts Market Share by Type (2016-2027)
Figure 27. Europe Soft Tissue Allografts Market Share by Application (2016-2027)
Figure 28. Europe Soft Tissue Allografts Market Share by Country (2016-2027)
Figure 29. Germany Soft Tissue Allografts Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Soft Tissue Allografts Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Soft Tissue Allografts Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Soft Tissue Allografts Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Soft Tissue Allografts Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Soft Tissue Allografts Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Soft Tissue Allografts Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Soft Tissue Allografts Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Soft Tissue Allografts Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Soft Tissue Allografts Market Share by Region (2016-2027)
Figure 39. China Soft Tissue Allografts Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Soft Tissue Allografts Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Soft Tissue Allografts Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Soft Tissue Allografts Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Soft Tissue Allografts Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Soft Tissue Allografts Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Soft Tissue Allografts Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Soft Tissue Allografts Market Share by Type (2016-2027)
Figure 47. Latin America Soft Tissue Allografts Market Share by Application (2016-2027)
Figure 48. Latin America Soft Tissue Allografts Market Share by Country (2016-2027)
Figure 49. Mexico Soft Tissue Allografts Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Soft Tissue Allografts Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Soft Tissue Allografts Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Soft Tissue Allografts Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Soft Tissue Allografts Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Soft Tissue Allografts Market Share by Country (2016-2027)
Figure 55. Turkey Soft Tissue Allografts Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Soft Tissue Allografts Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Soft Tissue Allografts Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Allergan Revenue Growth Rate in Soft Tissue Allografts Business (2016-2021)
Figure 59. B. Braun Melsungen Revenue Growth Rate in Soft Tissue Allografts Business (2016-2021)
Figure 60. CONMED Revenue Growth Rate in Soft Tissue Allografts Business (2016-2021)
Figure 61. Xtant Medical Holdings Revenue Growth Rate in Soft Tissue Allografts Business (2016-2021)
Figure 62. Alliqua BioMedical Revenue Growth Rate in Soft Tissue Allografts Business (2016-2021)
Figure 63. ALON SOURCE GROUP Revenue Growth Rate in Soft Tissue Allografts Business (2016-2021)
Figure 64. AlloSource Revenue Growth Rate in Soft Tissue Allografts Business (2016-2021)
Figure 65. C. R. Bard Revenue Growth Rate in Soft Tissue Allografts Business (2016-2021)
Figure 66. Arthrex Revenue Growth Rate in Soft Tissue Allografts Business (2016-2021)
Figure 67. Bone Bank Allografts Revenue Growth Rate in Soft Tissue Allografts Business (2016-2021)
Figure 68. Osiris Therapeutics Revenue Growth Rate in Soft Tissue Allografts Business (2016-2021)
Figure 69. MiMedx Group Revenue Growth Rate in Soft Tissue Allografts Business (2016-2021)
Figure 70. Integra LifeSciences Revenue Growth Rate in Soft Tissue Allografts Business (2016-2021)
Figure 71. Organogenesis Revenue Growth Rate in Soft Tissue Allografts Business (2016-2021)
Figure 72. RTI Surgical Revenue Growth Rate in Soft Tissue Allografts Business (2016-2021)
Figure 73. Lattice Biologics Revenue Growth Rate in Soft Tissue Allografts Business (2016-2021)
Figure 74. Globus Medical Revenue Growth Rate in Soft Tissue Allografts Business (2016-2021)
Figure 75. Zimmer Biomet Holdings Revenue Growth Rate in Soft Tissue Allografts Business (2016-2021)
Figure 76. Straumann Holding Revenue Growth Rate in Soft Tissue Allografts Business (2016-2021)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed
世界の軟骨軟組織同種移植市場規模・現状・予測（2021年-2027年） Soft Tissue Allograft surgery helps correct any problem that may arise from a receding gum line. Gum recession occurs when the gum tissue pulls away from the tooth, sometimes resulting in gum and tooth damage, tooth sensitivity, and tooth loss. Soft Tissue Allograft benefits patients that may need t…- 世界の軟部組織同種移植市場規模・現状・予測（2021年-2027年） Soft Tissue Allograft surgery helps correct any problem that may arise from a receding gum line. Gum recession occurs when the gum tissue pulls away from the tooth, sometimes resulting in gum and tooth damage, tooth sensitivity, and tooth loss. Soft Tissue Allograft benefits patients that may need t…
- 世界の軟部組織同種移植市場規模・現状・予測（2021年-2027年） Soft Tissue Allograft surgery helps correct any problem that may arise from a receding gum line. Gum recession occurs when the gum tissue pulls away from the tooth, sometimes resulting in gum and tooth damage, tooth sensitivity, and tooth loss. Soft Tissue Allograft benefits patients that may need t…
- 世界の軟骨用軟部組織同種移植市場 2021：企業別、地域別、種類・用途別 The Soft Tissue Allograft of Cartilage market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tr…
- 世界の同種移植市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Allografts Market The global Allografts market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant att…